Product & Functional Implementation Blueprint (V1)¶

Section 1 – Product Definition & Vision¶

1.1 Product Definition¶

Proposed Definition

Curaway.AI is an AI-assisted Recovery Intelligence Platform that delivers a Comprehensive Mobility Restoration Program (CMRP) for orthopaedic patients traveling from GCC countries to India. The platform combines empathetic patient engagement, evidence-based clinical intelligence, trusted provider collaboration, care coordination, and longitudinal recovery support to help patients make informed decisions and achieve optimal mobility outcomes.

Why this definition?

It intentionally avoids calling Curaway.AI:

• an AI chatbot
• a hospital management system
• a telemedicine platform
• a medical tourism platform because none of those represent the full vision.

Instead, it positions Curaway.AI as a Recovery Intelligence Platform delivering a Comprehensive Mobility Restoration Program.

1.2 MVP Objective¶

The MVP should have exactly one objective.

Proposed Objective

Enable orthopaedic patients from GCC countries to confidently choose, undergo, and recover from treatment in India through AI-assisted clinical decision support, empathetic engagement, coordinated care, and explainable recovery intelligence.

Notice what is not included:

• Population intelligence
• Marketplace
• Autonomous AI
• Multi-specialty support Those belong to later stages.

1.3 Target Users¶

The MVP focuses on a clearly defined ecosystem.

1.4 Geographic Scope¶

MVP

• Patient Origin: GCC (e.g., UAE, Saudi Arabia, Qatar, Oman, Kuwait, Bahrain)
• Treatment Destination: India

• Focus: Cross-border orthopaedic mobility restoration Later Phases

• India domestic

• Additional outbound regions
• Global provider network

1.5 Clinical Scope¶

MVP

Orthopaedic conditions affecting mobility where specialist evaluation and planned treatment can significantly improve function.

Illustrative examples:

• Knee Osteoarthritis
• Hip Osteoarthritis
• ACL Injury
• Meniscal Injury
• Shoulder Disorders
• Degenerative Spine Conditions (selected cases)
• Joint Replacement Pathways

• Sports Injuries requiring specialist evaluation Out of MVP

• Polytrauma

• Emergency orthopaedics
• ICU care
• Oncology
• Cardiology
• Neurology
• Obstetric care

1.6 Product Promise¶

Every patient interaction should move the patient toward one or more of these outcomes.

1.7 Core Experience Principles¶

1.8 What the MVP Is¶

Section 2 – Comprehensive Mobility Restoration Program (CMRP)¶

Purpose¶

This section defines the end-to-end operational journey of an orthopaedic patient traveling from GCC countries to India under Curaway.AI Comprehensive Mobility Restoration Program (CMRP).

The CMRP represents the primary product workflow for the MVP. It integrates clinical care, patient engagement, recovery intelligence, care coordination, cultural adaptation, and longitudinal recovery into a single, continuous experience.

2.1 Design Principles¶

The CMRP is built on the following principles.

2.2 CMRP Journey Stages¶

The MVP consists of nine operational stages.

2.3 Stage Structure¶

Every stage in this blueprint will follow the same template.

2.4 Stage 1 – Discovery & Trust Building¶

2.4.1 Purpose¶

The purpose of this stage is to establish the patient's initial relationship with Curaway.AI by building trust, reducing uncertainty, and introducing the Comprehensive Mobility Restoration Program (CMRP).

For many patients, this is the first interaction with Curaway.AI while they are seeking answers for a mobility-related health concern. At this stage, the patient may have limited clinical information, uncertainty regarding treatment options, and concerns about receiving care across international borders.

Curaway.AI engages the patient through empathetic, transparent, and personalized interactions that explain the recovery journey, introduce available services, address common concerns, and establish confidence in the platform before any clinical information is collected.

The objective of this stage is not to acquire a patient, but to establish sufficient trust for the patient to confidently begin their recovery journey.

The outcome of this stage is a Patient Engagement Record, initiating the patient's longitudinal relationship with Curaway.AI and preparing them for Stage 2 – Comprehensive Patient Understanding.

2.4.2 Stage Objectives¶

By the completion of this stage, Curaway.AI shall have achieved the following objectives.

2.4.3 Patient Objective¶

During this stage the patient wants to:

• Understand whether Curaway.AI can help.
• Learn how the treatment journey works.
• Understand why treatment in India is being recommended.
• Feel confident about engaging with Curaway.AI
• Understand what information will be required.
• Know how their privacy and medical information will be protected.
• Understand who will support them throughout the journey.
• Feel reassured before proceeding further. The patient should experience Curaway.AI as a trusted healthcare partner rather than a healthcare marketplace or medical tourism platform.

2.4.4 Curaway.AI Objective¶

Curaway.AI objective is to establish trust and create the foundation for a long-term recovery relationship.

Curaway.AI seeks to:

• Understand the patient's initial reason for engagement.
• Build confidence in the recovery journey.
• Demonstrate transparency.
• Explain the Comprehensive Mobility Restoration Program.
• Introduce the roles of the Care Coordinator, Orthopaedic Specialist, and AI Companion.
• Reduce uncertainty regarding cross-border healthcare.
• Encourage the patient to confidently proceed to the next stage. The objective is to create an environment where the patient feels comfortable sharing their recovery journey.

2.4.5 Primary Actors¶

2.4.6 Dynamic Interaction Logic (DIL) Behaviour¶

During this stage, Dynamic Interaction Logic (DIL) orchestrates the patient's first interactions with Curaway.AI

Rather than following a predefined onboarding sequence, DIL continuously adapts interactions based on the patient's needs, concerns, communication preferences, and level of understanding.

DIL continuously evaluates:

• Why is the patient engaging with Curaway.AI?
• What concerns or uncertainties are preventing engagement?
• What language and communication style are preferred?
• Does the patient require family participation?
• Does the patient require Care Coordinator support?
• Has sufficient trust been established?

• Is the patient ready to proceed to Comprehensive Patient Understanding? Based on this evaluation, DIL dynamically determines the next interaction, which may include:

• Introducing Curaway.AI and the Comprehensive Mobility Restoration Program.

• Explaining how the recovery journey works.
• Answering frequently asked questions.
• Explaining privacy, governance, and data protection.
• Explaining the role of AI and human clinicians.
• Introducing the Care Coordinator.
• Encouraging family participation where appropriate.
• Progressing the patient to the next stage. The objective of DIL during this stage is to establish trust while minimizing uncertainty and cognitive overload.

2.4.7 Interaction Principles¶

Every interaction shall adhere to Curaway.AI Experience Principles.

Empathy¶

Recognize that patients may be anxious, uncertain, or experiencing pain.

Trust¶

Communicate honestly, transparently, and without exaggeration.

Simplicity¶

Use language appropriate to the patient's health literacy and cultural background.

Transparency¶

Clearly explain how Curaway.AI works, what AI does, and when clinicians become involved.

Respect¶

Respect the patient's pace, preferences, and readiness to continue.

Human Collaboration¶

Patients should always know that qualified healthcare professionals remain responsible for clinical decisions.

2.4.8 Recovery Intelligence Evolution¶

Recovery Intelligence begins during the patient's first interaction with Curaway.AI

Recovery Observations¶

Examples include:

Patient

• Primary concern
• Preferred language
• Country of residence

• Communication preference Human

• Initial trust level

• Anxiety
• Expectations

• Information needs Care

• Family involvement

• Preferred communication channel
• Initial coordination requirements

Recovery States¶

Examples:

Engagement States

• Interested
• Exploring Care

• Ready to Engage Human States

• Trust Developing

• High Uncertainty Care States

• Care Coordinator Recommended

• Family Participation Recommended

Recovery Intelligence¶

Examples:

Human Intelligence

• Patient requires additional reassurance before continuing. Care Intelligence

• Arabic-speaking Care Coordinator recommended. Engagement Intelligence

• Patient ready to begin Comprehensive Patient Understanding. These outputs establish the initial HRDT context and personalize subsequent interactions throughout the recovery journey.

Section 2.4.9 – Intelligence Layer Activation¶

Purpose¶

During Discovery & Trust Building, the Curaway.AI Intelligence Platform focuses on establishing trust, understanding the patient's initial concerns, initiating the Human Recovery Digital Twin (HRDT), and determining the appropriate pathway for the patient's recovery journey.

Rather than performing clinical reasoning, the platform activates foundational intelligence capabilities to create a trusted, empathetic, and context-aware engagement experience while preparing the platform for deeper clinical understanding in subsequent stages.

Intelligence Layer Activation¶

2.4.10 Human Responsibilities¶

Care Coordinator¶

The Care Coordinator shall:

• Welcome the patient.
• Introduce Curaway.AI
• Build trust.
• Answer non-clinical questions.
• Explain the patient journey.
• Support family participation.
• Escalate concerns requiring clinical review.

2.4.11 Governance¶

During this stage the AI shall:

• Introduce Curaway.AI
• Explain the recovery journey.
• Answer general questions.
• Explain governance and privacy.
• Build trust.

• Operate within approved governance guardrails. The AI shall not:

• Provide diagnoses.

• Recommend treatment.
• Recommend hospitals.
• Recommend surgeons.
• Make clinical decisions.
• Operate outside approved governance policies.

2.4.12 Platform Capabilities¶

MVP¶

• Dynamic Interaction Logic (DIL)
• Patient Engagement Management
• Patient Registration
• Identity & Access Management
• Multilingual Communication
• Patient Education
• Care Coordinator Workspace
• Notification Service
• Consent Management
• Audit & Traceability
• HRDT Initialization

Future Evolution¶

• Personalized onboarding journeys
• Adaptive trust modelling
• Digital engagement optimization
• Voice-based interactions
• Regional personalization
• Predictive engagement intelligence

2.4.13 Functional Capabilities & Functional Requirements¶

2.4.14 Success Criteria¶

This stage is complete when:

• ✓ The patient understands Curaway.AI and the Comprehensive Mobility Restoration Program.
• ✓ Trust has been established to proceed with the recovery journey.
• ✓ Initial concerns and common questions have been addressed.
• ✓ Required consent and registration activities have been completed.
• ✓ Patient Engagement Record has been created.
• ✓ Initial HRDT context has been established.
• ✓ The patient is ready to enter Stage 2 – Comprehensive Patient Understanding.

Section 2.4.15 – Stage Output Artifact¶

Primary Stage Output Artifact¶

Artifact Contents¶

The Patient Engagement Record includes:

• Patient identity and demographic profile
• Contact and communication preferences
• Consent and governance status
• Initial presenting concern
• Preliminary symptom summary
• Preferred language and cultural preferences
• Geographic location and country of residence
• Initial mobility concerns
• Recovery aspirations and personal goals
• Emotional and trust indicators
• Initial provider interest
• Initial Recovery Baseline
• Initial Human Recovery Digital Twin (HRDT)
• Conversation history
• Care coordinator assignment (if applicable)

2.4.16 MVP vs Platform Evolution¶

2.5 Stage 2 – Comprehensive Patient Understanding¶

Purpose¶

The purpose of this stage is to develop a Comprehensive Patient Understanding through empathetic, Dynamic Interaction Logic (DIL)-driven interactions that progressively understand the patient's clinical condition, functional limitations, recovery challenges, personal goals, emotional wellbeing, family context, cultural preferences, financial considerations, and care needs.

Unlike traditional healthcare platforms that rely on static questionnaires and predefined workflows, Curaway.AI continuously develops an understanding of the patient through natural, contextual interactions supported by clinical evidence and human collaboration.

The outcome of this stage is a validated understanding of the patient's Recovery Reality, establishing the baseline Human Recovery Digital Twin (HRDT) and preparing the patient, clinician, and care team for informed, shared clinical decision-making.

2.5.1 Stage Objectives¶

By the completion of this stage, Curaway.AI shall have achieved the following objectives.

2.5.2 Patient Objective¶

During this stage the patient wants to:

• Be heard.
• Feel understood as a person, not merely as a medical case.
• Explain their problem naturally.
• Avoid repeatedly answering the same questions.
• Understand whether Curaway.AI can help.
• Build confidence in the care journey.
• Feel prepared for the specialist consultation. The interaction should feel like a conversation with an experienced orthopaedic care team rather than completing a digital form.

2.5.3 Curaway.AI Objective¶

Curaway.AI objective is not merely to collect information.

Its objective is to understand the patient's Recovery Reality across the Recovery Dimensions defined in the Metadata Dictionary.

Specifically, Curaway.AI seeks to understand:

Clinical Reality¶

• Presenting condition
• Symptom history
• Previous diagnosis
• Previous treatments
• Current medications
• Existing investigations

Recovery Reality¶

• Pain experience
• Functional limitations
• Mobility restrictions
• Activities affected
• Recovery goals

Human Reality¶

• Fear
• Confidence
• Expectations
• Motivation
• Decision readiness
• Trust

Care Reality¶

• Family support
• Travel readiness
• Financial readiness
• Caregiver availability
• Coordination needs

2.5.4 Primary Actors¶

2.5.5 Dimensions of Patient Understanding¶

Curaway.AI progressively develops understanding across eight complementary dimensions.

Clinical Understanding¶

Understand:

• Presenting complaint
• Symptom history
• Previous diagnoses
• Previous consultations
• Previous treatments
• Current medications
• Existing investigations
• Relevant medical history

Functional Understanding¶

Understand how the condition affects daily life.

Examples include:

• Walking
• Stair climbing
• Sitting
• Standing
• Driving
• Sleep
• Prayer
• Work
• Activities of daily living

Recovery Understanding¶

Understand:

• Recovery goals
• Desired mobility outcomes
• Previous rehabilitation
• Current recovery barriers
• Patient expectations regarding recovery

Human Understanding¶

Understand:

• Pain experience
• Anxiety
• Fear
• Confidence
• Motivation
• Expectations
• Quality of life
• Trust

Family Understanding¶

Understand:

• Primary decision maker
• Caregiver availability
• Family support
• Companion travel
• Family expectations

Cultural Understanding¶

Understand:

• Preferred language
• Communication preferences
• Religious considerations
• Dietary requirements
• Cultural expectations
• Gender preferences where appropriate

Financial Understanding¶

Understand:

• Funding source
• Insurance availability
• Budget expectations
• Financial concerns
• Affordability constraints

Decision Understanding¶

Understand:

• Patient awareness of the condition
• Understanding of available options
• Decision readiness
• Remaining uncertainties
• Questions requiring specialist clarification

2.5.6 Dynamic Interaction Logic (DIL) Behaviour¶

Dynamic Interaction Logic (DIL) orchestrates every interaction throughout this stage.

Rather than following predefined questionnaires or fixed conversation flows, DIL continuously determines the most appropriate interaction based on the patient's evolving Recovery Reality.

DIL continuously evaluates:

• What is already understood.
• What remains uncertain.
• Which dimension of patient understanding requires further exploration.
• Whether sufficient confidence has been achieved.
• Whether clarification is required.
• Whether empathy should take priority over information gathering.
• Whether family participation is appropriate.
• Whether Care Coordinator intervention is required.
• Whether clinician review is necessary.

• Whether governance permits progression to the next stage. Based on this evaluation, DIL dynamically determines the next interaction, which may include:

• Asking a contextual follow-up question.

• Clarifying contradictory information.
• Explaining a medical concept in patient-friendly language.
• Reassuring the patient.
• Requesting additional clinical evidence.
• Encouraging family participation.
• Escalating to the Care Coordinator.
• Preparing the Orthopaedic Specialist.
• Progressing to the next stage when confidence is sufficient. The objective of DIL is not to collect information, but to progressively develop a trusted understanding of the patient's Recovery Reality.

2.5.7 Interaction Principles¶

Every interaction shall adhere to the Curaway.AI Experience Principles.

Empathy¶

Every interaction acknowledges the patient's pain, concerns, and uncertainty.

Example:

Instead of asking:

"Rate your pain."

Curaway.AI may ask:

"Can you tell me how your knee problem has affected your daily life?"

Trust¶

Curaway.AI explains why information is being requested.

Example:

"Understanding how far you can comfortably walk helps the specialist understand how your mobility has been affected."

Context Awareness¶

Curaway.AI never asks questions for information that is already available through previous interactions or uploaded medical records.

Progressive Understanding¶

Each interaction builds on previous understanding rather than restarting the conversation.

Shared Decision Preparation¶

The conversation progressively prepares the patient for meaningful discussions with the orthopaedic specialist.

Human Collaboration¶

Whenever confidence is insufficient, emotional distress is detected, or governance requires human involvement, DIL seamlessly transitions the interaction to the appropriate healthcare professional.

2.5.8 Recovery Intelligence Evolution¶

Throughout the conversation, Curaway.AI continuously transforms interactions, clinical evidence, and observations into structured Recovery Intelligence.

Recovery Observations¶

Examples include:

Clinical

• Diagnosis
• Severity
• Previous interventions

• Investigation findings Recovery

• Pain

• Mobility limitations
• Functional restrictions

• Recovery goals Human

• Anxiety

• Confidence
• Motivation

• Trust Care

• Family support

• Travel readiness
• Financial readiness
• Coordination requirements

Recovery States¶

Examples:

Clinical States

• Suspected Advanced Knee Osteoarthritis

• Stable Clinical Status Recovery States

• Severe Mobility Limitation

• Moderate Functional Restriction Human States

• High Anxiety

• Strong Recovery Motivation

• Moderate Trust Care States

• Travel Ready

• Financially Constrained
• Strong Family Support

Recovery Intelligence¶

Examples:

Clinical Intelligence

• Missing investigations identified.

• Previous conservative management incomplete. Recovery Intelligence

• Significant mobility impairment.

• High rehabilitation potential. Human Intelligence

• Requires additional reassurance before treatment discussions. Care Intelligence

• Family participation recommended.

• Translation support required. These outputs contribute to the baseline Human Recovery Digital Twin (HRDT), enabling subsequent clinical reasoning and personalized recovery planning.

2.5.9 Intelligence Layer Activation¶

Purpose¶

During Comprehensive Patient Understanding, the Curaway.AI Intelligence Platform transforms initial patient engagement into a comprehensive, structured understanding of the patient's clinical condition, recovery aspirations, functional limitations, personal circumstances, and cross-border care requirements.

The intelligence layers work collaboratively to continuously analyse patient interactions, clinical evidence, medical history, recovery goals, emotional concerns, financial considerations, cultural preferences, caregiver support, and social context to develop a holistic understanding of the patient.

Rather than making treatment recommendations, this stage establishes the comprehensive patient context required for evidence-based clinical review and shared decision-making in the subsequent stage.

Intelligence Layer Activation¶

2.5.10 Human Responsibilities¶

Care Coordinator¶

The Care Coordinator shall:

• Welcome and orient the patient.
• Build trust throughout the interaction.
• Resolve non-clinical concerns.
• Coordinate missing documentation.
• Assist with translations where required.
• Support the patient and family.
• Escalate concerns outside AI governance boundaries.

Orthopaedic Specialist¶

Prior to consultation, the specialist shall:

• Review the AI-generated Comprehensive Patient Understanding.
• Validate important clinical findings.
• Review identified evidence gaps.
• Determine consultation readiness.
• Identify additional investigations where necessary.

2.5.11 Governance¶

During this stage the AI shall:

• Build understanding.
• Educate.
• Clarify.
• Summarize.
• Build trust.
• Identify missing information.
• Explain its reasoning.

• Operate within approved governance guardrails. The AI shall not:

• Independently diagnose.

• Recommend surgery.
• Promise outcomes.
• Pressure treatment decisions.
• Replace clinician judgement.
• Operate outside approved governance policies.

2.5.12 Platform Capabilities¶

MVP¶

• Dynamic Interaction Logic (DIL)
• Conversational Interaction Interface
• Clinical Document Management
• Medical Image Upload
• AI-assisted Clinical Summarization
• Conversation Memory
• Case Management
• Identity & Access Management
• Notification Service
• Audit & Traceability
• HRDT Initialization

Future Evolution¶

• Wearable Integration
• EMR Integration
• PACS Integration
• Passive Recovery Monitoring
• Digital Biomarker Integration
• Automated Imaging Interpretation
• Longitudinal HRDT Evolution

2.5.13 Functional Capabilities & Functional Requirements¶

The Comprehensive Patient Understanding stage is enabled through the following functional capabilities.

2.5.14 Success Criteria¶

This stage is complete when:

• ✓ The patient feels heard, understood, and supported.
• ✓ Comprehensive Patient Understanding has been established across all eight dimensions.
• ✓ The patient's Recovery Reality has been validated.
• ✓ Required clinical evidence has been collected or identified.
• ✓ Recovery Observations, Recovery States, and Recovery Intelligence have been generated.
• ✓ The baseline Human Recovery Digital Twin (HRDT) has been initialized.
• ✓ The Orthopaedic Specialist receives a structured Comprehensive Patient Understanding rather than unstructured medical records.
• ✓ The patient is prepared to enter Stage 3 – Decision Readiness & Specialist Consultation.

2.5.15 Stage Output Artifact¶

Primary Stage Output Artifact¶

Artifact Contents

The Comprehensive Patient Understanding Record (CPUR) includes:

• Comprehensive clinical history
• Presenting symptoms and progression
• Previous treatments, surgeries, and rehabilitation history
• Diagnostic reports and imaging references
• Functional mobility assessment
• Pain characteristics and impact
• Recovery goals and expected outcomes
• Lifestyle, occupation, and activity profile
• Emotional and psychological considerations
• Financial considerations and treatment expectations
• Cultural and language preferences
• Caregiver and family support assessment
• Cross-border care requirements
• Provider requirement profile
• Comprehensive Recovery Profile
• Updated Human Recovery Digital Twin (HRDT)
• Outstanding information gaps and coordination actions
• Patient understanding readiness assessment

2.5.16 MVP vs Platform Evolution¶

2.6 Stage 3 – Decision Readiness & Shared Clinical Decision Making¶

2.6.1 Purpose¶

The purpose of this stage is to enable the patient, family, orthopaedic specialist, and care team to reach a shared, informed, and evidence-based treatment decision that aligns with the patient's Recovery Reality.

Building upon the Comprehensive Patient Understanding established in Stage 2, Curaway.AI facilitates a collaborative decision-making process where clinical evidence, Recovery Intelligence, patient goals, functional expectations, emotional readiness, cultural values, family perspectives, and financial considerations are brought together transparently.

The objective of this stage is not to persuade the patient towards a particular treatment, but to ensure that every treatment decision is clinically appropriate, understandable, explainable, and aligned with the patient's mobility restoration goals.

The outcome of this stage is a Shared Decision Record, which becomes the foundation for the Personalized Mobility Restoration Plan in Stage 4.

2.6.2 Stage Objectives¶

By the completion of this stage, Curaway.AI shall have achieved the following objectives.

2.6.3 Patient Objective¶

During this stage the patient wants to:

• Understand the diagnosis.
• Understand available treatment options.
• Understand the benefits, risks, and limitations of each option.
• Understand expected recovery outcomes.
• Understand how treatment will affect daily life.
• Discuss concerns openly.
• Include family members in important decisions where appropriate.
• Feel confident before making a treatment decision.
• Trust that the recommendation is based on evidence and personal circumstances. The patient should feel that they are an active participant in the decision-making process rather than being told what to do.

2.6.4 Curaway.AI Objective¶

Curaway.AI objective is to facilitate a shared understanding that enables informed clinical decisions.

Curaway.AI continuously works to align:

• Clinical evidence
• Recovery Intelligence
• Patient goals
• Functional expectations
• Emotional readiness
• Family expectations
• Cultural preferences
• Financial considerations
• Clinical recommendations The objective is to ensure that every treatment decision reflects both clinical appropriateness and the patient's individual Recovery Reality.

2.6.5 Primary Actors¶

2.6.6 Dynamic Interaction Logic (DIL) Behaviour¶

During this stage, Dynamic Interaction Logic (DIL) shifts its focus from developing patient understanding to facilitating decision readiness.

DIL continuously evaluates:

• Does the patient understand their diagnosis?
• Does the patient understand available treatment options?
• Are the benefits and risks clearly understood?
• Are recovery expectations realistic?
• Is fear affecting the decision?
• Are financial concerns influencing the decision?
• Does the family require additional clarification?
• Has sufficient trust been established?
• Is specialist clarification required?

• Does governance permit progression to treatment planning? Based on this evaluation, DIL dynamically determines the next interaction, which may include:

• Explaining clinical findings in patient-friendly language.

• Presenting evidence supporting treatment recommendations.
• Clarifying misconceptions.
• Answering patient and family questions.
• Providing educational content.
• Encouraging family participation.
• Escalating to the orthopaedic specialist.
• Escalating to the Care Coordinator.
• Confirming decision readiness.
• Progressing to treatment planning. The objective of DIL during this stage is not to recommend treatment independently, but to ensure that the patient reaches an informed and confident decision.

2.6.7 Interaction Principles¶

Every interaction shall adhere to Curaway.AI Experience Principles.

Shared Understanding¶

Curaway.AI ensures that clinical recommendations are understood by both the patient and their family.

Transparency¶

Treatment options, supporting evidence, uncertainties, benefits, and risks are communicated openly.

Explainability¶

Every recommendation includes understandable clinical reasoning supported by appropriate evidence.

Patient Autonomy¶

The patient remains the decision-maker.

Curaway.AI supports informed choices without influencing decisions for commercial or non-clinical reasons.

Family Participation¶

Where appropriate, family members are included to support informed decisions.

Human Collaboration¶

Clinical decisions remain under the responsibility of qualified healthcare professionals.

Curaway.AI facilitates understanding but never replaces clinical judgement.

2.6.8 Recovery Intelligence Evolution¶

Recovery Intelligence evolves from patient understanding towards decision support.

Recovery Observations¶

Examples include:

Clinical

• Diagnosis confirmed

• Treatment alternatives identified Recovery

• Expected mobility improvement

• Recovery expectations Human

• Decision confidence

• Remaining concerns

• Trust level Care

• Family alignment

• Financial readiness
• Treatment logistics readiness

Recovery States¶

Examples:

Clinical States

• Treatment Recommendation Ready Recovery States

• Mobility Restoration Candidate Human States

• Decision Ready

• High Confidence Care States

• Family Aligned

• Financially Prepared

Recovery Intelligence¶

Examples:

Clinical Intelligence

• Evidence supports Total Knee Replacement. Recovery Intelligence

• Expected improvement in mobility and quality of life. Human Intelligence

• Additional reassurance required regarding recovery duration. Care Intelligence

• Family participation recommended before final consent. These outputs contribute to the patient's evolving HRDT and prepare the platform for personalized mobility restoration planning.

2.6.9 Intelligence Layer Activation¶

Purpose¶

During Shared Clinical Decision Making, the Curaway.AI Intelligence Platform transforms comprehensive patient understanding into clinically informed, evidence-based, transparent, and patient-centric treatment decisions.

At this stage, intelligence layers work collaboratively to synthesize clinical evidence, facilitate clinical review, coordinate independent medical second opinions where appropriate, evaluate suitable providers, compare treatment alternatives, explain recommendations, and support informed shared decision-making between the patient, clinicians, caregivers, and care coordinators.

The platform augments clinical expertise through intelligent evidence synthesis, recommendation comparison, explainability, and recovery impact analysis while ensuring that all clinical decisions remain under qualified healthcare professionals within established governance guardrails.

Intelligence Layer Activation¶

2.6.10 Human Responsibilities¶

Orthopaedic Specialist¶

The Orthopaedic Specialist shall:

• Review Comprehensive Patient Understanding.
• Explain diagnosis.
• Discuss treatment options.
• Explain benefits and risks.
• Answer patient and family questions.
• Validate AI-supported information.
• Recommend appropriate treatment.
• Confirm shared clinical decision.

Care Coordinator¶

The Care Coordinator shall:

• Facilitate patient understanding.
• Coordinate educational resources.
• Address logistical and financial questions.
• Support family communication.
• Prepare the patient for the next stage.
• Escalate concerns outside AI governance boundaries.

2.6.11 Governance¶

During this stage the AI shall:

• Explain treatment options.
• Present supporting evidence.
• Summarize specialist recommendations.
• Clarify terminology.
• Build understanding.
• Identify unanswered questions.
• Explain uncertainties.

• Operate within approved governance guardrails. The AI shall not:

• Recommend surgery independently.

• Override clinician recommendations.
• Pressure treatment decisions.
• Promise outcomes.
• Replace informed consent.
• Operate outside approved governance policies.

2.6.12 Platform Capabilities¶

MVP

• Dynamic Interaction Logic (DIL)
• Shared Decision Workspace
• Clinical Decision Support
• Evidence Presentation
• Explainable AI
• Consultation Workspace
• Recommendation Management
• Shared Decision Record
• Consent Management

• Audit & Traceability Future Evolution

• Personalized outcome simulation

• Predictive recovery visualization
• Multi-disciplinary decision support
• Comparative treatment analytics
• Adaptive decision coaching

2.6.13 Functional Capabilities & Functional Requirements¶

The Decision Readiness & Shared Clinical Decision-Making stage is enabled through the following functional capabilities.

2.6.14 Success Criteria¶

This stage is complete when:

• ✓ The patient understands the diagnosis.
• ✓ Available treatment options have been discussed.
• ✓ Benefits, risks, and uncertainties are understood.
• ✓ Patient and family questions have been addressed.
• ✓ Shared clinical decision has been reached.
• ✓ Treatment preference has been documented.
• ✓ Shared Decision Record has been created.
• ✓ The patient is confident and prepared to proceed.
• ✓ The patient is ready to enter Stage 4 – Personalized Mobility Restoration Planning.

2.6.15 Stage Output Artifact¶

Primary Stage Output Artifact¶

Artifact Contents¶

The Shared Clinical Decision Record (SCDR) includes:

• Comprehensive Patient Understanding Record (reference)
• Primary clinical review
• Independent medical second opinion (where applicable)
• Clinical recommendation summary
• Treatment alternatives evaluated
• Comparative treatment analysis
• Hospital and provider evaluation
• Clinical eligibility validation
• Expected recovery outcomes
• Benefits, risks, and clinical considerations
• Recovery impact assessment
• Patient questions and concerns
• Patient preferences
• Family and caregiver inputs
• Shared decision summary
• Decision rationale
• Informed consent status
• Selected provider and treatment pathway
• Updated Human Recovery Digital Twin (HRDT)
• Governance validation status
• Readiness for Comprehensive Mobility Restoration Planning (CMRP)

2.6.16 MVP vs Platform Evolution¶

2.7 Stage 4 – Personalized Mobility Restoration Planning¶

2.7.1 Purpose¶

The purpose of this stage is to transform the Shared Clinical Decision into a personalized, coordinated, and actionable Comprehensive Mobility Restoration Plan (CMRP Plan).

Building upon the Comprehensive Patient Understanding established in Stage 2 and the Shared Decision Record established in Stage 3, Curaway.AI collaboratively develops a holistic plan that integrates clinical treatment, mobility restoration goals, rehabilitation strategy, patient preferences, family participation, cultural considerations, financial planning, and cross-border care coordination.

The objective of this stage is to ensure that every patient begins treatment with a clear understanding of what will happen, why it will happen, who is responsible, and how success will be measured throughout the recovery journey.

The outcome of this stage is a validated Comprehensive Mobility Restoration Plan (CMRP Plan) that guides all subsequent care activities.

2.7.2 Stage Objectives

By the completion of this stage, Curaway.AI shall have achieved the following objectives.

2.7.3 Patient Objective¶

During this stage the patient wants to:

• Understand the complete treatment journey.
• Know what to expect before, during, and after treatment.
• Understand expected mobility improvements.
• Understand rehabilitation requirements.
• Know recovery timelines.
• Understand personal responsibilities.
• Understand family involvement.
• Feel confident and prepared before treatment begins. The patient should leave this stage with clarity, confidence, and realistic expectations regarding the entire recovery journey.

2.7.4 Curaway.AI Objective

Curaway.AI objective is to transform a treatment decision into a coordinated recovery journey.

Curaway.AI aligns:

• Clinical treatment
• Recovery objectives
• Mobility goals
• Functional milestones
• Patient expectations
• Family participation
• Cultural needs
• Financial planning
• Care coordination
• Rehabilitation planning The objective is to create a single, integrated plan that is understandable by the patient and executable by the care team.

2.7.5 Primary Actors¶

2.7.6 Dynamic Interaction Logic (DIL) Behaviour¶

During this stage, Dynamic Interaction Logic (DIL) orchestrates the creation of a personalized recovery plan.

DIL continuously evaluates:

• Are treatment goals aligned with patient goals?
• Are mobility expectations realistic?
• Are rehabilitation requirements understood?
• Are family responsibilities clear?
• Are cultural preferences reflected?
• Have financial considerations been addressed?
• Is travel planning required?
• Are all stakeholders aligned?

• Are governance requirements satisfied? Based on this evaluation, DIL dynamically determines the next interaction, which may include:

• Explaining the treatment pathway.

• Personalizing recovery milestones.
• Clarifying rehabilitation expectations.
• Identifying dependencies and risks.
• Coordinating multidisciplinary inputs.
• Preparing the patient for travel and treatment.
• Escalating unresolved concerns.
• Confirming readiness to proceed. The objective of DIL during this stage is to ensure that the Mobility Restoration Plan is personalized, coordinated, and fully understood before execution begins.

2.7.7 Interaction Principles¶

Every interaction shall adhere to Curaway.AI Experience Principles.

Personalization¶

Every plan reflects the patient's Recovery Reality rather than a standardized treatment pathway.

Shared Ownership¶

Recovery is presented as a collaborative responsibility shared by the patient, family, clinicians, rehabilitation team, and Curaway.AI

Transparency¶

Recovery milestones, responsibilities, expected outcomes, and uncertainties are communicated clearly.

Preparedness¶

Patients are proactively prepared for treatment, travel, rehabilitation, and recovery.

Continuity¶

Every stakeholder works from the same Mobility Restoration Plan.

Human Collaboration¶

Clinical decisions remain under clinician responsibility while Curaway.AI coordinates planning and communication.

2.7.8 Recovery Intelligence Evolution¶

Recovery Intelligence evolves from decision support to coordinated recovery planning.

Recovery Observations¶

Examples include:

Clinical

• Final treatment pathway
• Planned procedure

• Rehabilitation requirements Recovery

• Mobility goals

• Functional milestones

• Expected recovery timeline Human

• Confidence to proceed

• Recovery expectations

• Motivation Care

• Travel arrangements

• Family commitments
• Care coordination requirements

Recovery States¶

Examples:

Clinical States

• Treatment Planned Recovery States

• Mobility Restoration Plan Established Human States

• Confident to Proceed

• Recovery Expectations Aligned Care States

• Care Coordination Ready

• Cross-border Journey Ready

Recovery Intelligence¶

Examples:

Clinical Intelligence

• Treatment pathway validated. Recovery Intelligence

• Personalized mobility milestones established. Human Intelligence

• Additional education recommended before surgery. Care Intelligence

• Travel coordination and rehabilitation scheduling required. These outputs expand the HRDT and establish the operational roadmap for treatment delivery and recovery.

2.7.9 Intelligence Layer Activation¶

Purpose¶

During Shared Clinical Decision Making, the Curaway.AI Intelligence Platform transforms comprehensive patient understanding into clinically informed, evidence-based, transparent, and patient-centric treatment decisions.

At this stage, intelligence layers work collaboratively to synthesize clinical evidence, facilitate clinical review, coordinate independent medical second opinions where appropriate, evaluate suitable providers, compare treatment alternatives, explain recommendations, and support informed shared decision-making between the patient, clinicians, caregivers, and care coordinators.

The platform augments clinical expertise through intelligent evidence synthesis, recommendation comparison, explainability, and recovery impact analysis while ensuring that all clinical decisions remain under qualified healthcare professionals within established governance guardrails.

2.7.10 Human Responsibilities¶

Orthopaedic Specialist¶

The Orthopaedic Specialist shall:

• Confirm the clinical treatment pathway.
• Define treatment objectives.
• Establish expected clinical outcomes.
• Collaborate with the rehabilitation team.
• Approve the clinical components of the Mobility Restoration Plan.

Physiotherapist¶

The Physiotherapist shall:

• Define rehabilitation objectives.
• Establish functional recovery milestones.
• Recommend rehabilitation interventions.
• Educate the patient regarding recovery expectations.

Care Coordinator¶

The Care Coordinator shall:

• Coordinate multidisciplinary planning.
• Ensure alignment across stakeholders.
• Coordinate travel and treatment readiness activities.
• Confirm logistical readiness.
• Support patient and family throughout planning.

2.7.11 Governance¶

During this stage the AI shall:

• Personalize the Mobility Restoration Plan.
• Explain recovery milestones.
• Coordinate multidisciplinary inputs.
• Summarize responsibilities.
• Identify planning gaps.
• Explain uncertainties.

• Operate within approved governance guardrails. The AI shall not:

• Modify clinician-approved treatment plans.

• Replace clinical judgement.
• Make independent clinical commitments.
• Guarantee recovery outcomes.
• Operate outside approved governance policies.

2.7.12 Platform Capabilities¶

MVP¶

• Dynamic Interaction Logic (DIL)
• Comprehensive Mobility Restoration Plan Management
• Recovery Goal Management
• Mobility Milestone Management
• Rehabilitation Planning
• Multidisciplinary Care Planning
• Care Coordination Workspace
• Patient Education
• Recommendation Management
• Audit & Traceability
• HRDT Evolution

Future Evolution¶

• Dynamic care plan adaptation
• AI-assisted rehabilitation optimization
• Predictive milestone adjustment
• Automated multidisciplinary coordination
• Continuous recovery planning

2.7.13 Functional Capabilities & Functional Requirements¶

The Personalized Mobility Restoration Planning stage is enabled through the following functional capabilities.

2.7.14 Success Criteria¶

This stage is complete when:

• ✓ Comprehensive Mobility Restoration Plan has been created.
• ✓ Clinical treatment pathway has been finalized.
• ✓ Mobility restoration goals have been agreed.
• ✓ Rehabilitation pathway has been established.
• ✓ Patient and family responsibilities are understood.
• ✓ Care coordination activities have been initiated.
• ✓ Cross-border preparation requirements have been identified.
• ✓ All stakeholders are aligned.
• ✓ The patient is ready to enter Stage 5 – Treatment Preparation & Cross-border Coordination.

2.7.15 Stage Output Artifact¶

Primary Stage Output Artifact¶

Artifact Contents¶

The Comprehensive Mobility Restoration Plan (CMRP) includes:

• Shared Clinical Decision Record (reference)
• Confirmed treatment strategy
• Personalized recovery objectives
• Functional mobility goals
• Expected recovery milestones
• Prehabilitation plan
• Rehabilitation strategy
• Clinical preparation requirements
• Medical optimization activities
• Lifestyle modification recommendations
• Nutritional guidance (where applicable)
• Caregiver preparation plan
• Financial planning considerations
• Cross-border preparation requirements
• Travel readiness prerequisites
• Care coordination activities
• Clinical dependency schedule
• Recovery risk mitigation plan
• Expected recovery timeline
• Patient commitments and responsibilities
• Personalized follow-up framework
• Updated Human Recovery Digital Twin (HRDT)
• Governance validation status

2.7.16 MVP vs Platform Evolution¶

2.8 Stage 5 – Treatment Readiness & Cross-border Care Coordination¶

2.8.1 Purpose¶

The purpose of this stage is to ensure that every clinical, operational, logistical, financial, cultural, and care coordination dependency required for treatment has been validated and coordinated before the patient begins the treatment journey.

Building upon the Comprehensive Mobility Restoration Plan established in Stage 4, Curaway.AI orchestrates all stakeholders to ensure the patient is fully prepared to travel, receive treatment, and begin recovery with confidence.

The objective of this stage is not simply to coordinate travel, but to establish Treatment Readiness across the entire recovery ecosystem.

The outcome of this stage is a validated Treatment Readiness & Cross-border Care Coordination Plan, confirming that the patient, family, providers, hospital, and supporting services are aligned for treatment execution.

2.8.2 Stage Objectives¶

By the completion of this stage, Curaway.AI shall have achieved the following objectives.

2.8.3 Patient Objective¶

During this stage the patient wants to:

• Know exactly what happens next.
• Feel confident about travelling for treatment.
• Understand travel requirements.
• Understand hospital admission.
• Know who will support them throughout the journey.
• Ensure family members are informed.
• Resolve financial and logistical concerns.
• Feel fully prepared before treatment begins. The patient should never feel uncertain about the next step in the journey.

2.8.4 Curaway.AI Objective¶

Curaway.AI objective is to coordinate every dependency required to safely execute the Comprehensive Mobility Restoration Plan.

Curaway.AI aligns:

• Patient readiness
• Family readiness
• Clinical readiness
• Hospital readiness
• Care coordination
• Cross-border logistics
• Financial preparedness
• Cultural requirements
• Regulatory requirements
• Communication readiness The objective is to eliminate uncertainty before treatment begins.

2.8.5 Primary Actors¶

2.8.6 Dynamic Interaction Logic (DIL) Behaviour¶

During this stage, Dynamic Interaction Logic (DIL) shifts from planning to operational orchestration.

DIL continuously evaluates:

• Is the patient clinically ready?
• Are all required investigations complete?
• Has informed consent been completed?
• Is travel readiness confirmed?
• Are financial arrangements complete?
• Is accommodation arranged?
• Is family support available?
• Are hospital schedules confirmed?
• Are cultural preferences accommodated?
• Are regulatory requirements satisfied?

• Have all critical dependencies been completed? Based on this evaluation, DIL dynamically determines the next interaction, which may include:

• Explaining remaining readiness activities.

• Sending reminders for incomplete tasks.
• Coordinating appointments.
• Requesting missing documentation.
• Escalating unresolved issues to the Care Coordinator.
• Confirming hospital scheduling.
• Preparing the patient for admission.
• Confirming readiness to proceed. The objective of DIL during this stage is to ensure that no unresolved dependency prevents safe treatment execution.

2.8.7 Interaction Principles¶

Every interaction shall adhere to Curaway.AI Experience Principles.

Coordination¶

Every stakeholder has clear responsibilities and visibility into the treatment journey.

Preparedness¶

Patients receive proactive guidance before every milestone.

Transparency¶

Patients understand what is happening, why it is required, and who is responsible.

Continuity¶

The patient experiences one continuous journey rather than multiple disconnected services.

Cultural Sensitivity¶

Cross-border interactions respect language, customs, family participation, and cultural expectations.

Human Collaboration¶

Care Coordinators remain the primary human orchestrators throughout this stage.

2.8.8 Recovery Intelligence Evolution¶

Recovery Intelligence evolves from planning into execution readiness.

Recovery Observations¶

Clinical

• Investigations complete
• Surgical clearance obtained

• Admission scheduled Recovery

• Treatment readiness confirmed

• Rehabilitation schedule prepared Human

• Patient confidence

• Travel anxiety

• Family preparedness Care

• Visa completed

• Travel booked
• Accommodation confirmed
• Hospital ready
• Care coordination completed

Recovery States¶

Examples:

Clinical States

• Treatment Ready Recovery States

• Ready for Mobility Restoration Human States

• Confident to Travel

• Well Prepared Care States

• Cross-border Coordination Complete

• Hospital Ready

Recovery Intelligence¶

Examples:

Clinical Intelligence

• No outstanding clinical dependencies. Recovery Intelligence

• Ready to begin mobility restoration. Human Intelligence

• Patient requires additional reassurance before travel. Care Intelligence

• Companion travel confirmed.

• Airport transfer required. These outputs prepare the HRDT for the treatment execution phase.

2.8.9 Intelligence Layer Activation¶

Purpose¶

During Treatment Readiness & Cross-border Care Coordination, the Curaway.AI Intelligence Platform transforms the Comprehensive Mobility Restoration Plan (CMRP) into an executable treatment journey by coordinating all clinical, operational, logistical, administrative, financial, and cross-border activities required before treatment.

The intelligence layers collaborate to ensure that the patient, caregivers, healthcare providers, hospitals, and support ecosystem are fully prepared for treatment while proactively identifying and resolving dependencies, risks, delays, and coordination challenges.

Rather than delivering care, this stage ensures that every prerequisite for safe, efficient, and seamless treatment execution has been completed.

2.8.10 Human Responsibilities¶

Care Coordinator¶

The Care Coordinator shall:

• Coordinate all readiness activities.
• Monitor completion of dependencies.
• Coordinate travel and accommodation.
• Confirm hospital scheduling.
• Support patient and family.
• Resolve logistical issues.
• Escalate unresolved concerns.

Orthopaedic Specialist¶

The Orthopaedic Specialist shall:

• Confirm clinical readiness.
• Review outstanding investigations.
• Approve treatment commencement.

Hospital Care Team¶

The Hospital Care Team shall:

• Prepare admission.
• Confirm resource availability.
• Coordinate pre-operative requirements.
• Prepare for treatment delivery.

2.8.11 Governance¶

During this stage the AI shall:

• Monitor readiness.
• Coordinate activities.
• Explain requirements.
• Generate reminders.
• Identify missing dependencies.
• Escalate unresolved issues.

• Operate within approved governance guardrails. The AI shall not:

• Override clinical clearance.

• Modify treatment schedules without authorization.
• Make financial commitments.
• Replace human care coordination.
• Operate outside approved governance policies.

2.8.12 Platform Capabilities¶

MVP¶

• Dynamic Interaction Logic (DIL)
• Treatment Readiness Management
• Care Coordination Workspace
• Cross-border Coordination Management
• Task & Dependency Management
• Appointment & Scheduling Management
• Notification & Reminder Service
• Document Management
• Consent Tracking
• Audit & Traceability
• HRDT Evolution

Future Evolution¶

• Automated travel coordination
• Global provider integration
• Predictive readiness analytics
• Intelligent dependency management
• Autonomous care orchestration

2.8.13 Functional Capabilities & Functional Requirements¶

The Treatment Readiness & Cross-border Care Coordination stage is enabled through the following functional capabilities.

2.8.14 Success Criteria¶

This stage is complete when:

• ✓ Treatment Readiness has been established.
• ✓ Clinical readiness has been confirmed.
• ✓ Cross-border care coordination is complete.
• ✓ Patient and family are prepared.
• ✓ Hospital admission is confirmed.
• ✓ Travel and accommodation arrangements are complete.
• ✓ Outstanding dependencies have been resolved or acknowledged.
• ✓ Treatment Readiness & Care Coordination Plan has been finalized.
• ✓ The patient is ready to enter Stage 6 – Treatment Delivery.

2.8.15 Stage Output Artifact¶

Primary Stage Output Artifact¶

Artifact Contents¶

The Treatment Readiness Package (TRP) includes:

• Comprehensive Mobility Restoration Plan (CMRP) (reference)
• Confirmed hospital and specialist allocation
• Final treatment schedule
• Admission confirmation
• Clinical clearance status
• Medical optimization completion
• Prehabilitation completion status
• Medical visa documentation status
• Travel itinerary and logistics
• Accommodation arrangements
• Caregiver and companion plan
• Airport transfer and local mobility arrangements
• Interpreter and patient support services (where applicable)
• Financial readiness confirmation
• Required approvals and consent status
• Pre-treatment checklist completion
• Care coordination schedule
• Cross-border dependency tracker
• Risk mitigation and contingency plan
• Updated Human Recovery Digital Twin (HRDT)
• Governance validation status

2.8.16 MVP vs Platform Evolution¶

2.9 Stage 6 – Treatment Delivery & Early Recovery¶

2.9.1 Purpose¶

The purpose of this stage is to safely execute the agreed treatment pathway while initiating early recovery and mobility restoration.

Building upon the Treatment Readiness & Cross-border Care Coordination Plan established in Stage 5, Curaway.AI coordinates the patient, orthopaedic specialist, hospital care team, rehabilitation professionals, family, and supporting services to ensure that treatment is delivered safely, consistently, and in accordance with the Comprehensive Mobility Restoration Plan (CMRP).

The objective of this stage is not merely to complete treatment, but to establish the strongest possible foundation for successful recovery.

The outcome of this stage is a validated Treatment & Early Recovery Record, documenting treatment delivery, immediate recovery status, and readiness for structured rehabilitation.

2.9.2 Stage Objectives¶

By the completion of this stage, Curaway.AI shall have achieved the following objectives.

2.9.3 Patient Objective¶

During this stage the patient wants to:

• Feel safe throughout treatment.
• Understand what is happening.
• Receive coordinated care.
• Manage pain effectively.
• Know what recovery should look like.
• Begin regaining mobility.
• Keep family informed.
• Feel supported throughout hospitalization. The patient should never feel abandoned or uncertain during treatment.

2.9.4 Curaway.AI Objective¶

Curaway.AI objective is to ensure that treatment execution remains aligned with the Comprehensive Mobility Restoration Plan while continuously supporting the patient's early recovery.

Curaway.AI aligns:

• Clinical treatment
• Hospital care
• Recovery monitoring
• Mobility progression
• Pain management
• Patient education
• Family communication
• Care coordination
• Early rehabilitation The objective is to transition the patient safely from treatment into active recovery.

2.9.5 Primary Actors¶

2.9.6 Dynamic Interaction Logic (DIL) Behaviour¶

During this stage, Dynamic Interaction Logic (DIL) orchestrates treatment execution while continuously adapting interactions to the patient's evolving recovery status.

DIL continuously evaluates:

• Has treatment been completed as planned?
• Is the patient clinically stable?
• Is pain appropriately managed?
• Is early mobilization progressing?
• Is the patient understanding post-treatment instructions?
• Are complications or unexpected events occurring?
• Does the family require updates?
• Does the care team require additional coordination?

• Is the patient ready to transition toward structured rehabilitation? Based on this evaluation, DIL dynamically determines the next interaction, which may include:

• Explaining treatment progress.

• Reinforcing post-treatment instructions.
• Encouraging early mobility.
• Monitoring recovery concerns.
• Providing education regarding expected recovery.
• Coordinating multidisciplinary communication.
• Escalating concerns to the clinical team.
• Supporting family communication.
• Preparing the transition to rehabilitation. The objective of DIL during this stage is to maintain continuity, confidence, and coordinated recovery throughout treatment delivery.

2.9.7 Interaction Principles¶

Every interaction shall adhere to Curaway.AI Experience Principles.

Safety¶

Patient safety remains the highest priority.

Reassurance¶

Patients receive continuous explanations and emotional support throughout treatment.

Continuity¶

Recovery begins immediately after treatment and remains connected to the original Mobility Restoration Plan.

Transparency¶

Patients and families understand treatment progress and expected next steps.

Coordination¶

Every healthcare professional contributes within a coordinated recovery framework.

Human Collaboration¶

Clinical decisions remain under the responsibility of the treating healthcare team while Curaway.AI supports coordination, communication, and recovery.

2.9.8 Recovery Intelligence Evolution¶

Recovery Intelligence evolves from treatment planning into active recovery monitoring.

Recovery Observations¶

Clinical

• Treatment completed
• Clinical status
• Pain management
• Immediate complications

• Medication updates Recovery

• Early mobilization

• Functional improvement
• Mobility progression

• Rehabilitation readiness Human

• Confidence

• Anxiety
• Pain experience

• Motivation Care

• Family engagement

• Hospital coordination
• Discharge readiness
• Care transition planning

Recovery States¶

Examples:

Clinical States

• Treatment Completed

• Clinically Stable Recovery States

• Early Recovery Initiated

• Mobility Restoration Started Human States

• Reassured

• Motivated Care States

• Discharge Planning Ready

• Rehabilitation Ready

Recovery Intelligence¶

Examples:

Clinical Intelligence

• Recovery progressing as expected. Recovery Intelligence

• Early mobility milestones achieved. Human Intelligence

• Patient requires additional reassurance regarding recovery pain. Care Intelligence

• Home support required following discharge. These outputs continuously update the HRDT and establish the baseline for structured rehabilitation.

2.9.9 Intelligence Layer Activation¶

Purpose¶

During Treatment Delivery & Early Recovery, the Curaway Intelligence Platform orchestrates the patient's treatment episode while continuously monitoring clinical progress, coordinating multidisciplinary care, adapting recovery activities, and ensuring a safe transition from treatment to structured rehabilitation.

The intelligence layers operate collaboratively to maintain situational awareness across the patient's clinical status, treatment progress, provider activities, recovery observations, operational coordination, and emerging risks. The platform proactively supports clinicians, care coordinators, patients, and caregivers by identifying deviations, facilitating timely interventions, and maintaining continuity of care throughout the treatment episode.

Rather than influencing clinical decisions, the platform focuses on ensuring that treatment is executed safely, recovery is initiated effectively, and the patient is prepared for the next phase of mobility restoration.

2.9.10 Human Responsibilities¶

Orthopaedic Specialist

The Orthopaedic Specialist shall:

• Deliver agreed treatment.
• Monitor immediate clinical recovery.
• Review treatment outcomes.
• Define post-treatment clinical instructions.
• Confirm readiness for rehabilitation.

Hospital Care Team¶

The Hospital Care Team shall:

• Deliver inpatient nursing care.
• Monitor patient safety.
• Manage medications.
• Support patient education.
• Coordinate discharge activities.

Physiotherapist¶

The Physiotherapist shall:

• Initiate early mobilization.
• Assess functional recovery.
• Educate the patient regarding exercises.
• Prepare the rehabilitation pathway.

Care Coordinator¶

The Care Coordinator shall:

• Maintain continuity of care.
• Coordinate communication across providers.
• Support patient and family.
• Prepare transition to rehabilitation.
• Resolve coordination issues.

2.9.11 Governance¶

During this stage the AI shall:

• Explain treatment progress.
• Reinforce clinical instructions.
• Support patient education.
• Monitor recovery interactions.
• Coordinate communication.
• Escalate concerns.

• Operate within approved governance guardrails. The AI shall not:

• Modify clinical treatment.

• Replace inpatient clinical monitoring.
• Diagnose complications.
• Override clinician judgement.
• Guarantee recovery outcomes.
• Operate outside approved governance policies.

2.9.12 Platform Capabilities¶

MVP¶

• Dynamic Interaction Logic (DIL)
• Treatment Journey Management
• Recovery Monitoring
• Patient Education
• Family Communication
• Care Coordination Workspace
• Early Mobility Tracking
• Clinical Documentation
• Notification Service
• Audit & Traceability
• HRDT Evolution

Future Evolution¶

• Real-time bedside integration
• Wearable recovery monitoring
• Predictive complication detection
• Digital biomarker monitoring
• Adaptive inpatient recovery guidance

2.9.13 Functional Capabilities & Functional Requirements¶

The Treatment Delivery & Early Recovery stage is enabled through the following functional capabilities.

2.9.14 Success Criteria¶

This stage is complete when:

• ✓ Treatment has been delivered according to the agreed pathway.
• ✓ The patient is clinically stable.
• ✓ Early recovery has been successfully initiated.
• ✓ Initial mobility restoration activities have commenced.
• ✓ Pain management is established.
• ✓ Patient and family understand post-treatment expectations.
• ✓ Treatment & Early Recovery Record has been completed.
• ✓ The patient is ready to enter Stage 7 – Recovery & Rehabilitation.

2.9.15 Stage Output Artifact¶

Primary Stage Output Artifact¶

Artifact Contents¶

The Treatment & Early Recovery Record (TERR) includes:

• Treatment Readiness Package (reference)
• Treatment episode summary
• Surgical and procedural outcomes
• Clinical observations and progress notes
• Post-operative recovery status
• Pain management status
• Early mobility assessment
• Functional recovery observations
• Clinical interventions performed
• Medication and discharge prescriptions
• Rehabilitation initiation status
• Discharge planning summary
• Patient and caregiver education provided
• Complication assessment and mitigation actions
• Care coordination activities completed
• Post-discharge follow-up schedule
• Recovery risk assessment
• Updated Human Recovery Digital Twin (HRDT)
• Governance validation status

2.9.16 MVP vs Platform Evolution¶

2.10 Stage 7 – Mobility Restoration & Recovery¶

2.10.1 Purpose

The purpose of this stage is to restore the patient's mobility, functional independence, and quality of life through personalized rehabilitation, continuous Recovery Intelligence, and coordinated multidisciplinary care.

Building upon the Treatment & Early Recovery Record established in Stage 6, Curaway.AI continuously monitors recovery progress, adapts rehabilitation activities, supports patient engagement, coordinates care teams, and ensures that recovery remains aligned with the Comprehensive Mobility Restoration Plan (CMRP).

The objective of this stage is not merely to complete rehabilitation activities, but to achieve meaningful, measurable improvements in mobility and functional outcomes.

The outcome of this stage is a validated Mobility Restoration & Recovery Record, documenting recovery progress, mobility outcomes, rehabilitation achievements, and readiness for long-term recovery management.

2.10.2 Stage Objectives¶

By the completion of this stage, Curaway.AI shall have achieved the following objectives.

2.10.3 Patient Objective¶

During this stage the patient wants to:

• Walk comfortably again.
• Regain independence.
• Return to normal daily activities.
• Reduce pain.
• Build confidence in movement.
• Understand recovery progress.
• Stay motivated.
• Receive continued support.
• Know that recovery is progressing as expected. The patient should experience recovery as a guided journey rather than an isolated rehabilitation program.

2.10.4 Curaway.AI Objective¶

Curaway.AI objective is to coordinate and continuously support the patient's mobility restoration journey.

Curaway.AI aligns:

• Rehabilitation activities
• Functional recovery
• Mobility milestones
• Pain management
• Patient engagement
• Clinical follow-up
• Family support
• Care coordination
• Recovery monitoring The objective is to maximize functional recovery while maintaining patient confidence, motivation, and continuity of care.

2.10.5 Primary Actors¶

2.10.6 Dynamic Interaction Logic (DIL) Behaviour¶

During this stage, Dynamic Interaction Logic (DIL) continuously adapts interactions based on the patient's evolving recovery journey.

DIL continuously evaluates:

• Is recovery progressing as expected?
• Are rehabilitation milestones being achieved?
• Is mobility improving?
• Is pain improving or worsening?
• Is the patient adhering to the rehabilitation program?
• Is motivation declining?
• Are complications emerging?
• Does the patient require additional education?
• Does the physiotherapist require intervention?
• Is specialist review required?

• Is the Mobility Restoration Plan still appropriate? Based on this evaluation, DIL dynamically determines the next interaction, which may include:

• Encouraging rehabilitation adherence.

• Reinforcing recovery education.
• Explaining expected recovery milestones.
• Motivating the patient.
• Identifying barriers to recovery.
• Escalating concerns to the physiotherapist.
• Coordinating specialist follow-up.
• Updating rehabilitation goals.
• Preparing the transition toward long-term recovery management. The objective of DIL during this stage is to continuously support mobility restoration while maintaining engagement, confidence, and coordinated care.

2.10.7 Interaction Principles¶

Every interaction shall adhere to Curaway.AI Experience Principles.

Motivation¶

Patients receive continuous encouragement throughout rehabilitation.

Empowerment¶

Patients understand that their participation directly contributes to successful recovery.

Progress Visibility¶

Recovery progress and mobility improvements are communicated clearly and meaningfully.

Continuity¶

Recovery remains connected to the original Comprehensive Mobility Restoration Plan.

Personalization¶

Recovery support adapts to the patient's evolving Recovery Reality.

Human Collaboration¶

Physiotherapists and clinicians remain responsible for rehabilitation decisions while Curaway.AI coordinates communication, engagement, and recovery intelligence.

2.10.8 Recovery Intelligence Evolution¶

Recovery Intelligence evolves from treatment monitoring into continuous recovery optimization.

Recovery Observations¶

Clinical

• Clinical healing
• Follow-up findings

• Medication adjustments Recovery

• Walking ability

• Range of motion
• Pain improvement
• Functional independence
• Rehabilitation adherence

• Recovery milestones achieved Human

• Confidence

• Motivation
• Emotional wellbeing

• Recovery satisfaction Care

• Family participation

• Physiotherapy attendance
• Care coordination
• Follow-up compliance

Recovery States¶

Examples:

Clinical States

• Recovering Well Recovery States

• Mobility Restored

• Rehabilitation Progressing Human States

• Highly Motivated

• Confident Care States

• Rehabilitation Coordinated

• Follow-up Active

Recovery Intelligence¶

Examples:

Clinical Intelligence

• Recovery progressing according to plan. Recovery Intelligence

• Mobility improving faster than expected. Human Intelligence

• Motivation declining; additional engagement recommended. Care Intelligence

• Additional physiotherapy sessions recommended. These outputs continuously enrich the HRDT and prepare the patient for long-term outcome management.

2.10.9 Intelligence Layer Activation¶

Purpose¶

During Mobility Restoration & Recovery, the Curaway.AI Intelligence Platform continuously monitors, guides, and optimizes the patient's functional recovery journey following treatment.

The intelligence layers collaborate to evaluate rehabilitation progress, monitor mobility restoration, detect recovery deviations, coordinate multidisciplinary rehabilitation activities, support home-country care continuity, and personalize recovery interventions based on the patient's evolving condition.

The platform proactively assists patients, caregivers, physiotherapists, clinicians, and care coordinators by ensuring that recovery remains aligned with the Comprehensive Mobility Restoration Plan (CMRP), enabling timely interventions whenever recovery deviates from expected outcomes.

The primary objective of this stage is to maximize functional recovery, restore independence, and safely transition the patient toward long-term health and quality of life.

2.10.10 Human Responsibilities¶

Physiotherapist¶

The Physiotherapist shall:

• Monitor rehabilitation progress.
• Assess functional recovery.
• Update mobility milestones.
• Adjust rehabilitation interventions.
• Educate and motivate the patient.

Orthopaedic Specialist¶

The Orthopaedic Specialist shall:

• Review recovery outcomes.
• Assess clinical healing.
• Address complications where necessary.
• Approve progression through recovery.

Care Coordinator¶

The Care Coordinator shall:

• Maintain continuity of care.
• Coordinate multidisciplinary follow-up.
• Support patient and family.
• Resolve coordination issues.
• Facilitate ongoing communication.

2.10.12 Platform Capabilities¶

MVP¶

• Dynamic Interaction Logic (DIL)
• Recovery Journey Management
• Rehabilitation Management
• Mobility Milestone Tracking
• Recovery Progress Monitoring
• Patient Engagement
• Patient Education
• Care Coordination Workspace
• Clinical Follow-up Management
• Audit & Traceability
• HRDT Evolution

Future Evolution¶

• Wearable integration
• AI recovery coaching
• Computer vision mobility assessment
• Passive recovery monitoring
• Digital biomarkers
• Adaptive rehabilitation optimization

2.10.13 Functional Capabilities & Functional Requirements¶

The Mobility Restoration & Recovery stage is enabled through the following functional capabilities.

2.10.14 Success Criteria¶

This stage is complete when:

• ✓ Mobility restoration goals have been substantially achieved.
• ✓ Functional recovery milestones have been completed.
• ✓ Rehabilitation program has been completed or transitioned to maintenance.
• ✓ Recovery outcomes have been documented.
• ✓ Patient understands long-term recovery recommendations.
• ✓ Mobility Restoration & Recovery Record has been completed.
• ✓ HRDT has been updated with recovery outcomes.
• ✓ Patient is ready to enter Stage 8 – Longitudinal Recovery & Continuous Care.

2.10.15 Stage Output Artifact¶

Primary Stage Output Artifact¶

Artifact Contents

The Mobility Restoration & Recovery Record (MRRR) includes:

• Treatment & Early Recovery Record (reference)
• Rehabilitation progress summary
• Physiotherapy outcomes
• Functional mobility assessments
• Recovery milestone achievements
• Pain management progression
• Range of motion improvements
• Strength and endurance assessments
• Functional independence status
• Recovery adherence and engagement metrics
• Home-country physician coordination records
• Follow-up consultation summaries
• Complication monitoring and management history
• Recovery pathway adjustments
• Patient-reported outcome measures (PROMs)
• Quality of life assessments
• Updated Human Recovery Digital Twin (HRDT)
• Governance validation status
• Readiness for longitudinal recovery management

2.10.16 MVP vs Platform Evolution¶

2.11 Stage 8 – Longitudinal Recovery, Continuous Care & Lifelong Partnership¶

2.11.1 Purpose

The purpose of this stage is to sustain the patient's long-term mobility, functional independence, and quality of life through continuous Recovery Intelligence, proactive care coordination, and an enduring partnership between the patient, clinicians, and Curaway.

Building upon the Mobility Restoration & Recovery Record established in Stage 7, Curaway continues to monitor recovery outcomes, support long-term health, coordinate ongoing clinical care, encourage healthy behaviours, and continuously enrich the Human Recovery Digital Twin (HRDT).

The objective of this stage is not simply to perform follow-up, but to ensure that mobility restoration is sustained throughout the patient's life while continuously learning from every recovery journey to improve future patient outcomes.

The outcome of this stage is a continuously evolving Longitudinal Recovery Record, representing the patient's lifelong recovery journey and enabling future episodes of care to begin with a rich understanding of the patient's Recovery Reality.

2.11.2 Stage Objectives¶

By the completion of this stage, Curaway.AI shall have achieved the following objectives.

2.11.3 Patient Objective¶

During this stage the patient wants to:

• Maintain mobility and independence.
• Prevent recurrence or deterioration.
• Continue living without unnecessary pain.
• Receive guidance whenever needed.
• Stay connected with trusted clinicians.
• Monitor long-term progress.
• Receive timely follow-up and reminders.
• Feel supported throughout life, not only during treatment. The patient should experience Curaway.AI as a trusted lifelong recovery partner rather than a platform used only during treatment.

2.11.4 Curaway.AI Objective¶

Curaway.AI objective is to sustain and continuously improve the patient's Recovery Reality beyond the initial episode of care.

Curaway.AI aligns:

• Long-term mobility
• Functional independence
• Preventive care
• Lifestyle guidance
• Clinical follow-up
• Family engagement
• Recovery monitoring
• Patient education
• Continuous Recovery Intelligence
• HRDT evolution The objective is to transform episodic healthcare into continuous recovery partnership.

2.11.5 Primary Actors¶

2.11.6 Dynamic Interaction Logic (DIL) Behaviour¶

During this stage, Dynamic Interaction Logic (DIL) transitions from episode management to continuous longitudinal engagement.

DIL continuously evaluates:

• Is mobility being maintained?
• Are functional outcomes sustained?
• Is pain recurring?
• Are lifestyle recommendations being followed?
• Has the patient's Recovery Reality changed?
• Are new clinical concerns emerging?
• Does the patient require specialist review?
• Does rehabilitation need to restart?
• Are preventive interventions appropriate?

• Has the HRDT evolved sufficiently to improve future care? Based on this evaluation, DIL dynamically determines the next interaction, which may include:

• Checking on long-term recovery.

• Encouraging healthy behaviours.
• Reinforcing mobility maintenance.
• Providing educational content.
• Scheduling periodic follow-up.
• Identifying early warning signs.
• Escalating to clinicians.
• Recommending reassessment.
• Preparing for future episodes of care when necessary. The objective of DIL during this stage is to maintain continuous patient engagement while proactively protecting long-term mobility outcomes.

2.11.7 Interaction Principles¶

Every interaction shall adhere to Curaway.AI Experience Principles.

Continuity¶

Recovery remains a continuous journey rather than a completed episode.

Prevention¶

Interactions emphasize maintaining health and preventing deterioration.

Partnership¶

Curaway.AI remains a trusted partner throughout the patient's recovery journey.

Proactive Care¶

Potential issues are identified and addressed before they become significant problems.

Personalization¶

Long-term engagement evolves as the patient's Recovery Reality changes.

Human Collaboration¶

Longitudinal care remains coordinated between the patient, clinicians, rehabilitation professionals, and Curaway.AI

2.11.8 Recovery Intelligence Evolution¶

Recovery Intelligence evolves into lifelong learning and continuous improvement.

Recovery Observations¶

Clinical

• Long-term clinical outcomes
• Follow-up findings

• New orthopedic conditions Recovery

• Sustained mobility

• Functional independence
• Lifestyle adherence

• Recurrence indicators Human

• Quality of life

• Confidence
• Long-term wellbeing

• Patient satisfaction Care

• Follow-up compliance

• Family engagement
• Ongoing coordination
• Preventive interventions

Recovery States¶

Examples:

Clinical States

• Long-term Stable Recovery States

• Mobility Sustained

• Functional Independence Maintained Human States

• Highly Confident

• Engaged Care States

• Longitudinal Care Active

• Preventive Monitoring Active

Recovery Intelligence¶

Examples:

Clinical Intelligence

• No evidence of deterioration. Recovery Intelligence

• Long-term mobility successfully maintained. Human Intelligence

• Patient requires renewed motivation to maintain exercise adherence. Care Intelligence

• Annual orthopaedic review recommended. These outputs continuously enrich the Human Recovery Digital Twin (HRDT), ensuring that every future interaction benefits from the patient's complete recovery history while contributing to Curaway.AI evolving Recovery Intelligence ecosystem.

2.11.9 Intelligence Layer Activation¶

Purpose¶

During Longitudinal Recovery, Continuous Care & Lifelong Partnership, the Curaway.AI Intelligence Platform continuously supports the patient's long-term health and recovery by maintaining an evolving understanding of the patient's physical, functional, emotional, and clinical well-being beyond the completion of treatment.

The intelligence layers collaborate to monitor long-term recovery outcomes, facilitate periodic health reviews, coordinate ongoing clinical follow-up, support preventive care, identify emerging health concerns, strengthen patient engagement, and continuously enrich the Human Recovery Digital Twin (HRDT) with longitudinal health intelligence.

Rather than managing an isolated treatment episode, this stage establishes Curaway.AI as the patient's trusted lifelong healthcare companion by enabling continuous recovery optimization, proactive health management, and sustained patient-provider relationships.

Intelligence Layer Activation¶

2.11.10 Human Responsibilities¶

Orthopaedic Specialist¶

The Orthopaedic Specialist shall:

• Monitor long-term orthopaedic outcomes.
• Review recurrence or deterioration.
• Recommend further interventions when required.
• Support preventive orthopaedic care.

Physiotherapist¶

The Physiotherapist shall:

• Support long-term mobility maintenance.
• Recommend ongoing exercise programs.
• Reassess functional recovery where required.

Care Coordinator¶

The Care Coordinator shall:

• Coordinate long-term follow-up.
• Maintain patient engagement.
• Support continuity of care.
• Coordinate future care episodes.
• Facilitate communication across providers.

2.11.11 Governance¶

During this stage the AI shall:

• Monitor longitudinal recovery and continuous patient engagement.
• Support ongoing recovery, wellness, and preventive care interactions.
• Encourage long-term adherence to recovery, rehabilitation, and healthy lifestyle recommendations.
• Identify changes in recovery progression, functional status, or emerging health concerns.
• Coordinate periodic follow-ups and continuity of care across providers.
• Provide explainable long-term recovery insights and guidance.
• Escalate patients to appropriate healthcare professionals when clinical review or intervention is required.

• Operate within approved governance guardrails. The AI shall not:

• Independently diagnose new medical conditions or complications.

• Modify long-term treatment or rehabilitation plans without clinician approval.
• Replace periodic clinical review or professional medical judgment.
• Prescribe medications or recommend invasive interventions.
• Guarantee long-term recovery or future health outcomes.
• Operate outside approved governance policies.

2.11.12 Platform Capabilities¶

MVP¶

• Dynamic Interaction Logic (DIL)
• Longitudinal Recovery Management
• Continuous Care Management
• Follow-up Management
• Patient Engagement
• Preventive Care Reminders
• Clinical Follow-up Coordination
• Recovery Outcome Tracking
• HRDT Evolution
• Audit & Traceability

Future Evolution¶

• Digital Recovery Companion
• Wearable Integration
• Predictive Recovery Intelligence
• Population Recovery Intelligence
• Continuous Behavioural Coaching
• Personalized Preventive Care
• Autonomous Longitudinal Care Orchestration

2.11.13 Functional Capabilities & Functional Requirements¶

The Longitudinal Recovery, Continuous Care & Lifelong Partnership stage is enabled through the following functional capabilities.

2.11.14 Success Criteria¶

This stage is considered successful when:

• ✓ Long-term mobility outcomes are being maintained.
• ✓ Functional independence is sustained.
• ✓ Ongoing follow-up has been established.
• ✓ Patient engagement remains active.
• ✓ HRDT continues to evolve through longitudinal observations.
• ✓ Recovery outcomes continue contributing to Recovery Intelligence.
• ✓ Future care episodes can begin with comprehensive longitudinal understanding.
• ✓ Curaway.AI remains the patient's trusted long-term recovery partner. Unlike previous stages, this stage does not have a terminal completion state. It represents a continuous lifecycle that persists until a new recovery episode begins or long-term care requirements change.

2.11.15 Stage Output Artifact¶

Primary Stage Output Artifact¶

2.11.16 MVP vs Platform Evolution¶

3. MVP Implementation Blueprint¶

Purpose¶

This chapter translates the Product & Functional Blueprint into an implementation-oriented view for engineering teams. It defines the MVP implementation strategy, business capability evolution, sprint sequencing, platform capability evolution, implementation scope, and engineering navigation while maintaining complete traceability to the business capabilities defined in Chapter 2.

The objective of this chapter is to provide engineering, product, and solution architecture teams with a common implementation blueprint for delivering the Curaway.AI MVP while preserving the long-term platform vision defined in the RIOS Blueprint, Platform Blueprint, Metadata Dictionary, and Unified Governance Framework.

3.1 MVP Implementation Principles¶

Purpose¶

Establish the implementation principles that govern the engineering and delivery of the Curaway.AI MVP.

These principles ensure that implementation decisions remain aligned with Curaway.AI business vision, Recovery Intelligence philosophy, platform architecture, and long-term evolution.

Implementation Principles¶

1. Capability-driven Development

Implementation shall be organized around business capabilities rather than individual screens, services, or user interface components.

1. Journey-first Implementation

The MVP shall demonstrate the complete patient journey from Discovery & Trust Building through Longitudinal Recovery.

1. Horizontal Platform Evolution

Dynamic Interaction Logic (DIL), Human Recovery Digital Twin (HRDT), Recovery Intelligence, Governance, Explainability, and Care Coordination shall evolve progressively across all implementation phases rather than being implemented as isolated components.

1. Human-in-the-loop by Design

Clinical diagnosis, treatment recommendations, and medical decisions shall always remain under qualified healthcare professionals.

1. AI-Augmented Care

Artificial Intelligence shall augment clinical decision-making, care coordination, and patient engagement while operating within approved governance guardrails.

1. Orthopaedic-first MVP

The MVP shall focus exclusively on the Comprehensive Mobility Restoration Program (CMRP) for GCC patients seeking orthopaedic treatment in India.

1. Platform before Optimization

Reusable platform capabilities shall be established before advanced automation or optimization features.

1. MVP before Scale

Implementation shall prioritize demonstrable business value before expanding to additional specialties, geographies, or advanced intelligence capabilities.

3.2 Business Capability Evolution Model¶

Purpose¶

Illustrate how Curaway.AI business capabilities evolve throughout the patient's recovery journey and establish the implementation sequence for the MVP.

Capability Evolution Flow¶

3.3 MVP Delivery Roadmap¶

Purpose

Define the phased implementation approach for delivering the Curaway.AI MVP while maintaining traceability to the Product & Functional Blueprint.

3.3.2 Capability Dependencies¶

3.3.3 MVP Release Roadmap¶

3.4 Platform Capability Evolution¶

Purpose

Describe how Curaway.AI core platform capabilities and intelligence layers evolve collaboratively across the eight-stage Comprehensive Mobility Restoration Program (CMRP). Rather than developing capabilities independently, the platform incrementally activates and enriches each capability throughout the patient journey, ensuring that business capabilities, platform services, and intelligence remain synchronized while delivering the MVP.

3.4.1 Platform Capability Evolution¶

3.4.2 Intelligence Layer Evolution Across Stages¶

Purpose

Illustrate how each intelligence layer contributes throughout the patient journey and how the layers collaborate to progressively build the patient's recovery journey.

3.5 MVP Scope¶

Purpose

Clearly define the implementation boundary for the Curaway.AI MVP and establish capabilities intentionally deferred to future platform releases.

3.5.1 MVP Scope¶

The Curaway.AI MVP includes:

• Comprehensive Mobility Restoration Program (Orthopaedics)
• GCC to India patient journey
• AI-guided patient engagement
• Dynamic Interaction Logic (DIL)
• Human Recovery Digital Twin (HRDT)
• Recovery Intelligence
• Clinical evidence management
• Shared clinical decision-making
• Personalized Mobility Restoration Planning (CMRP)
• Cross-border treatment coordination
• Treatment tracking
• Recovery monitoring
• Longitudinal follow-up
• Governance, explainability, auditability, and human oversight

3.5.2 Out of Scope¶

The following capabilities are intentionally excluded from the MVP:

• Multi-specialty clinical pathways
• Global provider marketplace
• Autonomous AI agents
• Wearable device integration
• Population Recovery Intelligence
• Predictive recovery analytics
• Insurance claims automation
• Advanced multilingual voice interactions
• Digital therapeutics
• Clinical research and trial management
• Public health analytics

3.6 Engineering Navigation Guide¶

Purpose

Provide engineering teams with a single-entry point for locating detailed implementation guidance across the Curaway.AI architecture documentation.